carepear
HEMOTAG Accepted Into NIH’s RADx Tech For Maternal Health Challenge
The company was selected for the Viability Assessment Phase and advance to the next phase of the Challenge, the Deep […]
Read MoreThe company was selected for the Viability Assessment Phase and advance to the next phase of the Challenge, the Deep […]
Read More